Consistent with this notion, expression of TCF7 (which encodes TCF1) broadly correlates with responses to CAR T cell2,5, tumour-infiltrating lymphocyte (TIL)8 and checkpoint blockade9,10 therapies. The gene discussed is TCF7; the disease is neoplasm.